Literature DB >> 27312022

CAV3 mutations causing exercise intolerance, myalgia and rhabdomyolysis: Expanding the phenotypic spectrum of caveolinopathies.

Renata Siciliani Scalco1, Alice R Gardiner2, Robert D S Pitceathly3, David Hilton-Jones4, Anthony H Schapira2, Chris Turner2, Matt Parton2, Mahalekshmi Desikan2, Rita Barresi5, Julie Marsh6, Adnan Y Manzur7, Anne-Marie Childs8, Lucy Feng7, Elaine Murphy9, Phillipa J Lamont10, Gianina Ravenscroft11, William Wallefeld12, Mark R Davis12, Nigel G Laing13, Janice L Holton2, Doreen Fialho2, Kate Bushby14, Michael G Hanna2, Rahul Phadke15, Heinz Jungbluth16, Henry Houlden2, Ros Quinlivan15.   

Abstract

Rhabdomyolysis is often due to a combination of environmental trigger(s) and genetic predisposition; however, the underlying genetic cause remains elusive in many cases. Mutations in CAV3 lead to various neuromuscular phenotypes with partial overlap, including limb girdle muscular dystrophy type 1C (LGMD1C), rippling muscle disease, distal myopathy and isolated hyperCKemia. Here we present a series of eight patients from seven families presenting with exercise intolerance and rhabdomyolysis caused by mutations in CAV3 diagnosed by next generation sequencing (NGS) (n = 6). Symptoms included myalgia (n = 7), exercise intolerance (n = 7) and episodes of rhabdomyolysis (n = 2). Percussion-induced rapid muscle contractions (PIRCs) were seen in five out of six patients examined. A previously reported heterozygous mutation in CAV3 (p.T78M) and three novel variants (p.V14I, p.F41S, p.F54V) were identified. Caveolin-3 immunolabeling in muscle was normal in 3/4 patients; however, immunoblotting showed more than 50% reduction of caveolin-3 in five patients compared with controls. This case series demonstrates that exercise intolerance, myalgia and rhabdomyolysis may be caused by CAV3 mutations and broadens the phenotypic spectrum of caveolinopathies. In our series, immunoblotting was a more sensitive method to detect reduced caveolin-3 levels than immunohistochemistry in skeletal muscle. Patients presenting with muscle pain, exercise intolerance and rhabdomyolysis should be routinely tested for PIRCs as this may be an important clinical clue for caveolinopathies, even in the absence of other "typical" features. The use of NGS may expand current knowledge concerning inherited diseases, and unexpected/atypical phenotypes may be attributed to well-known human disease genes.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CAV3; Caveolinopathy; Exercise Intolerance; Myalgia; Myoglobinuria; Rhabdomyolysis

Mesh:

Substances:

Year:  2016        PMID: 27312022     DOI: 10.1016/j.nmd.2016.05.006

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  10 in total

1.  Exome sequencing in Jewish and Arab patients with rhabdomyolysis reveals single-gene etiology in 43% of cases.

Authors:  Asaf Vivante; Hadas Ityel; Ben Pode-Shakked; Jing Chen; Shirlee Shril; Amelie T van der Ven; Nina Mann; Johanna Magdalena Schmidt; Reeval Segel; Adi Aran; Avraham Zeharia; Orna Staretz-Chacham; Omer Bar-Yosef; Annick Raas-Rothschild; Yuval E Landau; Richard P Lifton; Yair Anikster; Friedhelm Hildebrandt
Journal:  Pediatr Nephrol       Date:  2017-08-05       Impact factor: 3.714

Review 2.  The Limb-Girdle Muscular Dystrophies: Is Treatment on the Horizon?

Authors:  Mary Lynn Chu; Ellen Moran
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

Review 3.  Pediatric Paroxysmal Exercise-Induced Neurological Symptoms: Clinical Spectrum and Diagnostic Algorithm.

Authors:  Federica Rachele Danti; Federica Invernizzi; Isabella Moroni; Barbara Garavaglia; Nardo Nardocci; Giovanna Zorzi
Journal:  Front Neurol       Date:  2021-06-01       Impact factor: 4.003

4.  Exertional rhabdomyolysis: physiological response or manifestation of an underlying myopathy?

Authors:  Renata S Scalco; Marc Snoeck; Ros Quinlivan; Susan Treves; Pascal Laforét; Heinz Jungbluth; Nicol C Voermans
Journal:  BMJ Open Sport Exerc Med       Date:  2016-09-07

5.  Panorama of the distal myopathies.

Authors:  Marco Savarese; Jaakko Sarparanta; Anna Vihola; Per Harald Jonson; Mridul Johari; Salla Rusanen; Peter Hackman; Bjarne Udd
Journal:  Acta Myol       Date:  2020-12-01

Review 6.  Biomarkers in Glycogen Storage Diseases: An Update.

Authors:  Alberto Molares-Vila; Alberte Corbalán-Rivas; Miguel Carnero-Gregorio; José Luís González-Cespón; Carmen Rodríguez-Cerdeira
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

7.  Chronic pain has a strong impact on quality of life in facioscapulohumeral muscular dystrophy.

Authors:  Germán Morís; Libby Wood; Roberto FernáNdez-Torrón; José Andrés González Coraspe; Chris Turner; David Hilton-Jones; Fiona Norwood; Tracey Willis; Matt Parton; Mark Rogers; Simon Hammans; Mark Roberts; Elizabeth Househam; Maggie Williams; Hanns Lochmüller; Teresinha Evangelista
Journal:  Muscle Nerve       Date:  2017-11-07       Impact factor: 3.217

8.  Caveolin-3 deficiency associated with the dystrophy P104L mutation impairs skeletal muscle mitochondrial form and function.

Authors:  Dinesh S Shah; Raid B Nisr; Clare Stretton; Gabriela Krasteva-Christ; Harinder S Hundal
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-02-23       Impact factor: 12.910

9.  Clinical presentation and proteomic signature of patients with TANGO2 mutations.

Authors:  Nadja Mingirulli; Angela Pyle; Denisa Hathazi; Charlotte L Alston; Nicolai Kohlschmidt; Gina O'Grady; Leigh Waddell; Frances Evesson; Sandra B T Cooper; Christian Turner; Jennifer Duff; Ana Topf; Delia Yubero; Cristina Jou; Andrés Nascimento; Carlos Ortez; Angels García-Cazorla; Claudia Gross; Maria O'Callaghan; Saikat Santra; Maryanne A Preece; Michael Champion; Sergei Korenev; Efsthatia Chronopoulou; Majumdar Anirban; Germaine Pierre; Daniel McArthur; Kyle Thompson; Placido Navas; Antonia Ribes; Frederic Tort; Agatha Schlüter; Aurora Pujol; Raquel Montero; Georgia Sarquella; Hanns Lochmüller; Cecilia Jiménez-Mallebrera; Robert W Taylor; Rafael Artuch; Janbernd Kirschner; Sarah C Grünert; Andreas Roos; Rita Horvath
Journal:  J Inherit Metab Dis       Date:  2019-08-13       Impact factor: 4.982

10.  Targeted gene panel use in 2249 neuromuscular patients: the Australasian referral center experience.

Authors:  Sarah J Beecroft; Kyle S Yau; Mark R Davis; Nigel G Laing; Richard J N Allcock; Kym Mina; Rebecca Gooding; Fathimath Faiz; Vanessa J Atkinson; Cheryl Wise; Padma Sivadorai; Daniel Trajanoski; Nina Kresoje; Royston Ong; Rachael M Duff; Macarena Cabrera-Serrano; Kristen J Nowak; Nicholas Pachter; Gianina Ravenscroft; Phillipa J Lamont
Journal:  Ann Clin Transl Neurol       Date:  2020-03-09       Impact factor: 4.511

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.